PharmaFarm – Recent Publications

Thank you for visiting our site! PharmaFarm desires to understand the business and development issues that influence the success of new pharmaceutical start-ups. We hope that by gaining a better understanding of these processes we can help future start-up companies more easily navigate the difficult road of ophthalmic pharmaceutical development.

Please visit other website pages to learn more about PharmaFarm research and services!

Stewart WC, Nelson LA, Eveleth DD. Endothelial Regeneration: Help Is on the Way. Review Ophthalmol 2015 Nov;74-80.

Sharpe RA, Austin JP, Kruft B, Nelson LA, Stewart JA, Stewart WC. Description of ophthalmic pharmaceutical and device start-up companies. Ophthalmic Res 2015;54:6-9. INFOGRAPHIC

Stewart WC, Stewart JA, Nelson LA. How to assess an ophthalmic start-up. Review Ophthalmol 2015 Apr;62-69. http://www.reviewofophthalmology.com/content/i/3233/c/54164/

Stewart WC, Stewart JA, Nelson LA. First steps in creating a pharma start-up. Review Ophthalmol 2014 Apr;54-62. http://www.revophth.com/content/c/47509/

Stewart WC, Chaney PG, Stewart JA, Kruft B, Nelson LA.  Qualitative factors underlying the successful investment in new ophthalmic pharmaceutical products in the United States. Acta Ophthalmol. 2013;91:496-497.

Stewart WC, Stewart JA, Nelson LA.  The start-up: From dream to reality. Review Ophthalmol 2013;Apr:62-71.  http://www.revophth.com/content/c/40144/

Stewart WC, Stewart JA, Kruft B, Nelson LA.  Challenges facing ophthalmic startup companies in developing new devices or medicines. Acta Ophthalmol 2013;91 e81-83

Under review

Stewart WC, Burns WR, Stewart JA, Nelson LA. Practice patterns to treat presbyopia.
Stewart WC, Stewart JA, Nelson LA. Ophthalmic community perception of new medication needs.
Stewart WC, Nelson LA, Kruft B, Stewart JA. Ophthalmic start-up CEO’s perceptions of development hurdles.
Stewart WC, Kruft B, Nelson LA, Stewart JA. Progress of ophthalmic pharmaceutical start-up companies
Stewart WC, Stewart JA, Nelson LA. What data sources do ophthalmologists trust?
Stewart WC, Hernandez SM, Nelson LA. Incidence of new start-up creation over five years associated with new ophthalmic molecules, or older medicines evaluated for new indications.
Stewart WC, Hernandez SM, Nelson LA, Stewart JA. Results of orphan drug designations in ophthalmology.